Back to the main directory
EarningsReview / Equity
- FCC approves TMUS deals with US Cellular and MetroNet by BNP Paribas Exane
- 2Q25 preliminary results missed on weak lithium prices by BNP Paribas Exane
- Vestum - Weak margin but organic growth on the upside by Danske Bank Equity Research
- Non material data changes by BNP Paribas Exane
- Non material data changes by BNP Paribas Exane
- Q2 Results - What to Expect? by BNP Paribas Exane
- Solstad Maritime - Leaving H1 behind with strong growth guided for H2 by Danske Bank Equity Research
- Monthly musings: Focus to shift to the demand side by BNP Paribas Exane
- Non material data changes by BNP Paribas Exane
- Ola Electric Mobility (OLAELEC IN) by HSBC
- HCL Technologies (HCLT IN) by HSBC
- 2H25 comps not that easy, 2026 FX hedging headwinds by BNP Paribas Exane
- Q225: Where do we stand on the Caution Barometer? by BNP Paribas Exane
- CEO for a day by BNP Paribas Exane
- Lifco - Hold: A bittersweet bite by Nordea
- Sagax - Buy/SEK 285 (290): Acquisitions and vacancies supportive for the case by Nordea
- Q225 trading: material beat by BNP Paribas Exane
- Inwido - Buy/SEK 236 (245): Taking market share by Nordea
- Addnode - Buy/SEK 130 (120): Broad divisional strength behind Q2 beat by Nordea
- Q1 sales first take: a few different items in the basket by BNP Paribas Exane
- FY Q3-25 AuA and Flows First Take by BNP Paribas Exane
- European Taxonomy: confirmed changes from 2025 reporting onwards by Oddo BHF
- INVEST SECURITIES - BIOPHYTIS : Amélioration de la PN due à une baisse des dépenses R&D - NEUTRE, OC 0,77€ by Invest Securities
- RIO, CHINA MACRO, CHINA HOUSING, CHINA CREDIT, STEEL US, STEEL CHINA, NEM, LITHIUM by BNP Paribas Exane
- Towards $100bn+ of annual capex, without RPO or return visibility by BNP Paribas Exane
- CEO transition, strategic review, preliminary 2Q25 growth below cons. by BNP Paribas Exane
- 1QFY26 preview: Early monsoon could lead strong growth by BNP Paribas Exane
- Non material data changes by BNP Paribas Exane
- 2Q25 preliminary results: recurring loss wider than expected by BNP Paribas Exane
- Expect weak 1H; maintained FY guidance; focus on cash by BNP Paribas Exane
- Evonik, Lanxess, Wacher Chemie: coverage dropped by BNP Paribas Exane
- Guidance upgrade after strong Q2 25 prelims by BNP Paribas Exane
- Growth confidence; margin hit transitory by BNP Paribas Exane
- Guidance revised down by BNP Paribas Exane
- Jarir Marketing Co (JARIR AB) by HSBC
- Sustainability Weekly 7 – 11 Juillet 2025 by Oddo BHF
- What could motivate large merchants to use stablecoins? by BNP Paribas Exane
- Post-initiation feedback on Zealand (+), SOBI (-), Lundbeck (=) by BNP Paribas Exane
- Hexatronic - Price pressure and new wave of volume weakness by Danske Bank Equity Research
- Coor Service Management - Buy/SEK 53 (43): Norway saves the day by Nordea
- When the Trend is Not Your Friend: US Market Share Hits Multi-Year Low; Maintain Underperform by BNP Paribas Exane
- NOTE - Sell/SEK 127 (125): Driven by defence and greentech; M&A promised by Nordea
- Volati - Buy/SEK 155 (159): Streamlined for a rebound by Nordea
- Q2 25 first look - strong margin helped by IPR one-off but weak Q3 25 guidance by BNP Paribas Exane
- Taxonomie européenne : des allègements confirmés dès le reporting 2025 by Oddo BHF
- Q1FY’26 Results: First Take. Strong growth led by N America by BNP Paribas Exane
- Ryanair; known or unknown?, US tariffs, Container shipping, Air travel outlook, Aena, French politics, Wizz Air, Low-cost long-haul flights, Groupe ADP, Heathrow by BNP Paribas Exane
- Non material data changes by BNP Paribas Exane
- Conference call feedback by BNP Paribas Exane
- 2Q25 pre-close call feedback by BNP Paribas Exane